Mad Money

Cramer's lightning round: Emergent BioSolutions is worth a buy

Share
Key Points
  • It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Apex Technology Acquisition: "Blank-check company. ... We've got to do more work on it."

Jumia Technologies: "I think you've got to let it cool off a little."

GrowGeneration: "I think this stock has been a rocket ship. I want rocket ships to cool off."

Emergent BioSolutions: "I think this stock is just going down, down, down because there hasn't been any news flow, so I say that one's OK to buy."

Cassava Sciences: "We have to be very careful with the pain-management ones. ... I've got to do more work on that because if I get too far ahead of something and it doesn't' work, then I will have made a big mistake."

Interpublic Group of Companies: "That stock is still inexpensive. I think IPG is good. The stock is still way below where the rest of the market is."

Sumo Logic: "It's a very crowded space. ... I can't just go recommending this one. No, not right here, not right now."

VIDEO5:2505:25
Cramer's lightning round: Emergent BioSolutions is worth a buy

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com